Share Price and Basic Stock Data
Last Updated: March 8, 2025, 9:55 am
| PEG Ratio | 1.58 |
|---|
Competitors of Zensar Technologies Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.57/0.33 | 1.14 | 0.00 % | 0.88 % | 0.82 % | 1.00 | |
| Mudunuru Ltd | 22.6 Cr. | 7.23 | 15.6/5.41 | 0.34 | 0.00 % | 72.9 % | 374 % | 2.00 | |
| Naapbooks Ltd | 94.7 Cr. | 105 | 159/54.0 | 40.6 | 20.0 | 0.00 % | 17.4 % | 13.6 % | 10.0 |
| IB Infotech Enterprises Ltd | 21.1 Cr. | 165 | 245/113 | 27.1 | 16.8 | 0.61 % | 69.9 % | 50.5 % | 10.0 |
| Hit Kit Global Solutions Ltd | 7.19 Cr. | 1.55 | 1.55/0.91 | 20.0 | 2.08 | 0.00 % | 1.92 % | 1.94 % | 2.00 |
| Industry Average | 19,195.34 Cr | 566.73 | 79.98 | 121.67 | 0.84% | 21.53% | 64.55% | 6.83 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,102 | 1,154 | 1,203 | 1,235 | 1,198 | 1,213 | 1,227 | 1,241 | 1,204 | 1,230 | 1,288 | 1,308 | 1,326 |
| Expenses | 944 | 990 | 1,067 | 1,129 | 1,063 | 1,037 | 997 | 1,010 | 996 | 1,027 | 1,092 | 1,107 | 1,119 |
| Operating Profit | 158 | 164 | 136 | 105 | 135 | 176 | 230 | 231 | 208 | 203 | 196 | 201 | 207 |
| OPM % | 14% | 14% | 11% | 9% | 11% | 14% | 19% | 19% | 17% | 17% | 15% | 15% | 16% |
| Other Income | 24 | 72 | 21 | 28 | 26 | 27 | 28 | 36 | 42 | 52 | 42 | 41 | 31 |
| Interest | 9 | 9 | 6 | 8 | 8 | 6 | 6 | 6 | 6 | 3 | 4 | 4 | 4 |
| Depreciation | 47 | 48 | 49 | 49 | 50 | 35 | 42 | 37 | 31 | 24 | 25 | 30 | 24 |
| Profit before tax | 126 | 180 | 102 | 77 | 104 | 162 | 210 | 225 | 212 | 229 | 210 | 208 | 210 |
| Tax % | 27% | 27% | 26% | 26% | 26% | 26% | 26% | 23% | 24% | 24% | 25% | 25% | 24% |
| Net Profit | 92 | 131 | 75 | 57 | 76 | 119 | 156 | 174 | 162 | 173 | 158 | 156 | 160 |
| EPS in Rs | 4.02 | 5.74 | 3.32 | 2.51 | 3.38 | 5.27 | 6.90 | 7.68 | 7.14 | 7.65 | 6.97 | 6.86 | 7.04 |
Last Updated: February 28, 2025, 4:04 pm
Below is a detailed analysis of the quarterly data for Zensar Technologies Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹1,326.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,308.00 Cr. (Sep 2024) to ₹1,326.00 Cr., marking an increase of ₹18.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹1,119.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,107.00 Cr. (Sep 2024) to ₹1,119.00 Cr., marking an increase of ₹12.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹207.00 Cr.. The value appears strong and on an upward trend. It has increased from 201.00 Cr. (Sep 2024) to ₹207.00 Cr., marking an increase of ₹6.00 Cr..
- For OPM %, as of Dec 2024, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Sep 2024) to 16.00%, marking an increase of 1.00%.
- For Other Income, as of Dec 2024, the value is ₹31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Sep 2024) to ₹31.00 Cr., marking a decrease of 10.00 Cr..
- For Interest, as of Dec 2024, the value is ₹4.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 4.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 30.00 Cr. (Sep 2024) to ₹24.00 Cr., marking a decrease of 6.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹210.00 Cr.. The value appears strong and on an upward trend. It has increased from 208.00 Cr. (Sep 2024) to ₹210.00 Cr., marking an increase of ₹2.00 Cr..
- For Tax %, as of Dec 2024, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Sep 2024) to 24.00%, marking a decrease of 1.00%.
- For Net Profit, as of Dec 2024, the value is ₹160.00 Cr.. The value appears strong and on an upward trend. It has increased from 156.00 Cr. (Sep 2024) to ₹160.00 Cr., marking an increase of ₹4.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 7.04. The value appears strong and on an upward trend. It has increased from ₹6.86 (Sep 2024) to 7.04, marking an increase of ₹0.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 2:20 pm
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,129 | 2,335 | 2,656 | 2,952 | 3,056 | 3,108 | 3,966 | 4,182 | 3,781 | 4,244 | 4,848 | 4,902 | 5,151 |
| Expenses | 1,828 | 1,977 | 2,264 | 2,513 | 2,674 | 2,743 | 3,487 | 3,675 | 3,097 | 3,587 | 4,296 | 4,030 | 4,344 |
| Operating Profit | 300 | 358 | 392 | 439 | 382 | 365 | 479 | 507 | 685 | 656 | 552 | 872 | 807 |
| OPM % | 14% | 15% | 15% | 15% | 12% | 12% | 12% | 12% | 18% | 15% | 11% | 18% | 16% |
| Other Income | 3 | 30 | 27 | 54 | 24 | 74 | 93 | 88 | -24 | 138 | 103 | 159 | 166 |
| Interest | 10 | 10 | 11 | 11 | 9 | 23 | 37 | 61 | 54 | 35 | 28 | 21 | 15 |
| Depreciation | 33 | 38 | 42 | 65 | 49 | 65 | 89 | 159 | 175 | 185 | 183 | 134 | 102 |
| Profit before tax | 261 | 340 | 366 | 417 | 349 | 352 | 445 | 376 | 433 | 574 | 444 | 876 | 856 |
| Tax % | 33% | 30% | 28% | 30% | 32% | 30% | 28% | 28% | 29% | 27% | 26% | 24% | |
| Net Profit | 175 | 238 | 265 | 292 | 238 | 246 | 319 | 272 | 307 | 422 | 328 | 665 | 647 |
| EPS in Rs | 8.01 | 10.86 | 11.94 | 12.97 | 10.47 | 10.74 | 13.93 | 11.69 | 13.30 | 18.40 | 14.47 | 29.34 | 28.52 |
| Dividend Payout % | 20% | 18% | 18% | 18% | 23% | 22% | 20% | 24% | 27% | 27% | 35% | 31% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 36.00% | 11.34% | 10.19% | -18.49% | 3.36% | 29.67% | -14.73% | 12.87% | 37.46% | -22.27% | 102.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | -24.66% | -1.16% | -28.68% | 21.85% | 26.31% | -44.41% | 27.60% | 24.59% | -59.73% | 125.02% |
Zensar Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: November 14, 2024, 6:32 pm
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 44 | 44 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 685 | 902 | 1,113 | 1,220 | 1,427 | 1,624 | 1,897 | 2,045 | 2,297 | 2,642 | 2,931 | 3,517 | 3,660 |
| Borrowings | 200 | 170 | 176 | 149 | 134 | 9 | 300 | 332 | 350 | 335 | 273 | 186 | 147 |
| Other Liabilities | 328 | 370 | 402 | 455 | 500 | 618 | 847 | 1,174 | 742 | 817 | 872 | 899 | 970 |
| Total Liabilities | 1,257 | 1,486 | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 4,822 |
| Fixed Assets | 397 | 422 | 547 | 386 | 447 | 592 | 950 | 1,323 | 1,133 | 1,254 | 1,174 | 1,034 | 1,169 |
| CWIP | 2 | 2 | 1 | 2 | 3 | 6 | 12 | 11 | 0 | 1 | 0 | 5 | 6 |
| Investments | 42 | 149 | 94 | 134 | 243 | 275 | 115 | 278 | 517 | 324 | 899 | 1,408 | 1,564 |
| Other Assets | 815 | 914 | 1,092 | 1,347 | 1,413 | 1,424 | 2,013 | 1,983 | 1,783 | 2,260 | 2,049 | 2,200 | 2,084 |
| Total Assets | 1,257 | 1,486 | 1,734 | 1,869 | 2,106 | 2,296 | 3,090 | 3,596 | 3,433 | 3,840 | 4,121 | 4,648 | 4,822 |
Below is a detailed analysis of the balance sheet data for Zensar Technologies Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹45.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹45.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹3,660.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,517.00 Cr. (Mar 2024) to ₹3,660.00 Cr., marking an increase of 143.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹147.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹186.00 Cr. (Mar 2024) to ₹147.00 Cr., marking a decrease of 39.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹970.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹899.00 Cr. (Mar 2024) to ₹970.00 Cr., marking an increase of 71.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹4,822.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹4,648.00 Cr. (Mar 2024) to ₹4,822.00 Cr., marking an increase of 174.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹1,169.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,034.00 Cr. (Mar 2024) to ₹1,169.00 Cr., marking an increase of 135.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹6.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹5.00 Cr. (Mar 2024) to ₹6.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2024, the value is ₹1,564.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,408.00 Cr. (Mar 2024) to ₹1,564.00 Cr., marking an increase of 156.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹2,084.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹2,200.00 Cr. (Mar 2024) to ₹2,084.00 Cr., marking a decrease of 116.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹4,822.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹4,648.00 Cr. (Mar 2024) to ₹4,822.00 Cr., marking an increase of 174.00 Cr..
Notably, the Reserves (₹3,660.00 Cr.) exceed the Borrowings (147.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
No data available for this post.
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 100.00 | 188.00 | 216.00 | 290.00 | 248.00 | 356.00 | 179.00 | 175.00 | 335.00 | 321.00 | 279.00 | 686.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 56 | 62 | 67 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 |
| Inventory Days | 198 | 272 | 266 | 304 | ||||||||
| Days Payable | 200 | 300 | 283 | 400 | ||||||||
| Cash Conversion Cycle | 56 | 28 | 45 | -29 | 64 | 75 | 81 | 58 | 57 | 69 | 55 | 55 |
| Working Capital Days | 45 | 47 | 55 | 74 | 65 | 70 | 71 | 40 | 28 | 44 | 27 | 32 |
| ROCE % | 31% | 34% | 30% | 31% | 24% | 23% | 23% | 18% | 21% | 21% | 15% | 25% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Hybrid Equity Fund - Regular Plan | 5,750,731 | 1.47 | 330.24 | 3,334,492 | 2025-03-10 | 72.46% |
| Nippon India Small Cap Fund | 4,039,176 | 0.51 | 231.95 | 3,334,492 | 2025-03-10 | 21.13% |
| HSBC Value Fund | 3,524,000 | 1.8 | 202.37 | 3,334,492 | 2025-03-10 | 5.68% |
| ICICI Prudential Technology Fund | 3,334,492 | 1.56 | 191.48 | 3,334,492 | 2025-03-10 | 0% |
| Franklin India Smaller Companies Fund | 2,532,033 | 1.23 | 145.4 | 3,334,492 | 2025-03-10 | -24.07% |
| Tata Digital India Fund | 1,965,123 | 1.16 | 112.85 | 3,334,492 | 2025-03-10 | -41.07% |
| HSBC Aggressive Hybrid Fund | 1,910,000 | 2.13 | 109.68 | 3,334,492 | 2025-03-10 | -42.72% |
| HDFC Childrens Gift Fund - Regular Plan | 1,423,821 | 0.97 | 81.76 | 3,334,492 | 2025-03-10 | -57.3% |
| Nippon India Flexi Cap Fund | 989,733 | 0.95 | 56.84 | 3,334,492 | 2025-03-10 | -70.32% |
| Franklin India Technology Fund | 963,216 | 4.32 | 55.31 | 3,334,492 | 2025-03-10 | -71.11% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 29.36 | 14.47 | 18.43 | 13.31 | 11.69 |
| Diluted EPS (Rs.) | 29.13 | 14.40 | 18.27 | 13.18 | 11.69 |
| Cash EPS (Rs.) | 35.27 | 22.54 | 26.84 | 21.35 | 19.11 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 157.26 | 131.40 | 118.89 | 105.10 | 93.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 157.26 | 131.40 | 118.89 | 105.10 | 93.78 |
| Revenue From Operations / Share (Rs.) | 216.42 | 214.05 | 187.78 | 167.61 | 185.52 |
| PBDIT / Share (Rs.) | 45.50 | 28.92 | 35.14 | 31.48 | 26.42 |
| PBIT / Share (Rs.) | 39.59 | 20.84 | 26.96 | 23.74 | 19.36 |
| PBT / Share (Rs.) | 38.67 | 19.61 | 25.40 | 19.19 | 16.67 |
| Net Profit / Share (Rs.) | 29.36 | 14.46 | 18.66 | 13.61 | 12.05 |
| NP After MI And SOA / Share (Rs.) | 29.36 | 14.46 | 18.42 | 13.30 | 11.69 |
| PBDIT Margin (%) | 21.02 | 13.51 | 18.71 | 18.78 | 14.24 |
| PBIT Margin (%) | 18.29 | 9.73 | 14.35 | 14.16 | 10.43 |
| PBT Margin (%) | 17.86 | 9.16 | 13.52 | 11.44 | 8.98 |
| Net Profit Margin (%) | 13.56 | 6.75 | 9.93 | 8.11 | 6.49 |
| NP After MI And SOA Margin (%) | 13.56 | 6.75 | 9.80 | 7.93 | 6.29 |
| Return on Networth / Equity (%) | 18.66 | 11.00 | 15.49 | 12.80 | 12.60 |
| Return on Capital Employeed (%) | 23.63 | 14.46 | 20.03 | 19.87 | 17.06 |
| Return On Assets (%) | 14.30 | 7.94 | 10.75 | 8.73 | 7.32 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.08 | 0.00 | 0.03 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.08 | 0.00 | 0.13 |
| Asset Turnover Ratio (%) | 1.12 | 1.21 | 0.54 | 0.46 | 0.53 |
| Current Ratio (X) | 3.04 | 2.70 | 2.73 | 2.70 | 1.98 |
| Quick Ratio (X) | 3.04 | 2.70 | 2.73 | 2.70 | 1.89 |
| Dividend Payout Ratio (NP) (%) | 18.73 | 34.55 | 21.16 | 9.01 | 45.45 |
| Dividend Payout Ratio (CP) (%) | 15.59 | 22.16 | 14.65 | 5.69 | 28.33 |
| Earning Retention Ratio (%) | 81.27 | 65.45 | 78.84 | 90.99 | 54.55 |
| Cash Earning Retention Ratio (%) | 84.41 | 77.84 | 85.35 | 94.31 | 71.67 |
| Interest Coverage Ratio (X) | 49.31 | 23.48 | 22.50 | 13.27 | 9.84 |
| Interest Coverage Ratio (Post Tax) (X) | 32.82 | 12.74 | 12.95 | 7.65 | 5.49 |
| Enterprise Value (Cr.) | 12988.21 | 5476.97 | 7684.40 | 5517.20 | 1745.42 |
| EV / Net Operating Revenue (X) | 2.65 | 1.13 | 1.81 | 1.46 | 0.41 |
| EV / EBITDA (X) | 12.60 | 8.36 | 9.68 | 7.77 | 2.93 |
| MarketCap / Net Operating Revenue (X) | 2.80 | 1.28 | 1.96 | 1.64 | 0.46 |
| Retention Ratios (%) | 81.26 | 65.44 | 78.83 | 90.98 | 54.54 |
| Price / BV (X) | 3.85 | 2.08 | 3.09 | 2.64 | 0.93 |
| Price / Net Operating Revenue (X) | 2.80 | 1.28 | 1.96 | 1.64 | 0.46 |
| EarningsYield | 0.04 | 0.05 | 0.05 | 0.04 | 0.13 |
After reviewing the key financial ratios for Zensar Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 29.36. This value is within the healthy range. It has increased from 14.47 (Mar 23) to 29.36, marking an increase of 14.89.
- For Diluted EPS (Rs.), as of Mar 24, the value is 29.13. This value is within the healthy range. It has increased from 14.40 (Mar 23) to 29.13, marking an increase of 14.73.
- For Cash EPS (Rs.), as of Mar 24, the value is 35.27. This value is within the healthy range. It has increased from 22.54 (Mar 23) to 35.27, marking an increase of 12.73.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 157.26. It has increased from 131.40 (Mar 23) to 157.26, marking an increase of 25.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 157.26. It has increased from 131.40 (Mar 23) to 157.26, marking an increase of 25.86.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 216.42. It has increased from 214.05 (Mar 23) to 216.42, marking an increase of 2.37.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 45.50. This value is within the healthy range. It has increased from 28.92 (Mar 23) to 45.50, marking an increase of 16.58.
- For PBIT / Share (Rs.), as of Mar 24, the value is 39.59. This value is within the healthy range. It has increased from 20.84 (Mar 23) to 39.59, marking an increase of 18.75.
- For PBT / Share (Rs.), as of Mar 24, the value is 38.67. This value is within the healthy range. It has increased from 19.61 (Mar 23) to 38.67, marking an increase of 19.06.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 29.36. This value is within the healthy range. It has increased from 14.46 (Mar 23) to 29.36, marking an increase of 14.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 29.36. This value is within the healthy range. It has increased from 14.46 (Mar 23) to 29.36, marking an increase of 14.90.
- For PBDIT Margin (%), as of Mar 24, the value is 21.02. This value is within the healthy range. It has increased from 13.51 (Mar 23) to 21.02, marking an increase of 7.51.
- For PBIT Margin (%), as of Mar 24, the value is 18.29. This value is within the healthy range. It has increased from 9.73 (Mar 23) to 18.29, marking an increase of 8.56.
- For PBT Margin (%), as of Mar 24, the value is 17.86. This value is within the healthy range. It has increased from 9.16 (Mar 23) to 17.86, marking an increase of 8.70.
- For Net Profit Margin (%), as of Mar 24, the value is 13.56. This value exceeds the healthy maximum of 10. It has increased from 6.75 (Mar 23) to 13.56, marking an increase of 6.81.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 13.56. This value is within the healthy range. It has increased from 6.75 (Mar 23) to 13.56, marking an increase of 6.81.
- For Return on Networth / Equity (%), as of Mar 24, the value is 18.66. This value is within the healthy range. It has increased from 11.00 (Mar 23) to 18.66, marking an increase of 7.66.
- For Return on Capital Employeed (%), as of Mar 24, the value is 23.63. This value is within the healthy range. It has increased from 14.46 (Mar 23) to 23.63, marking an increase of 9.17.
- For Return On Assets (%), as of Mar 24, the value is 14.30. This value is within the healthy range. It has increased from 7.94 (Mar 23) to 14.30, marking an increase of 6.36.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.12. It has decreased from 1.21 (Mar 23) to 1.12, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 24, the value is 3.04. This value exceeds the healthy maximum of 3. It has increased from 2.70 (Mar 23) to 3.04, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 24, the value is 3.04. This value exceeds the healthy maximum of 2. It has increased from 2.70 (Mar 23) to 3.04, marking an increase of 0.34.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 18.73. This value is below the healthy minimum of 20. It has decreased from 34.55 (Mar 23) to 18.73, marking a decrease of 15.82.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 15.59. This value is below the healthy minimum of 20. It has decreased from 22.16 (Mar 23) to 15.59, marking a decrease of 6.57.
- For Earning Retention Ratio (%), as of Mar 24, the value is 81.27. This value exceeds the healthy maximum of 70. It has increased from 65.45 (Mar 23) to 81.27, marking an increase of 15.82.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 84.41. This value exceeds the healthy maximum of 70. It has increased from 77.84 (Mar 23) to 84.41, marking an increase of 6.57.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 49.31. This value is within the healthy range. It has increased from 23.48 (Mar 23) to 49.31, marking an increase of 25.83.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 32.82. This value is within the healthy range. It has increased from 12.74 (Mar 23) to 32.82, marking an increase of 20.08.
- For Enterprise Value (Cr.), as of Mar 24, the value is 12,988.21. It has increased from 5,476.97 (Mar 23) to 12,988.21, marking an increase of 7,511.24.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.65. This value is within the healthy range. It has increased from 1.13 (Mar 23) to 2.65, marking an increase of 1.52.
- For EV / EBITDA (X), as of Mar 24, the value is 12.60. This value is within the healthy range. It has increased from 8.36 (Mar 23) to 12.60, marking an increase of 4.24.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.80. This value is within the healthy range. It has increased from 1.28 (Mar 23) to 2.80, marking an increase of 1.52.
- For Retention Ratios (%), as of Mar 24, the value is 81.26. This value exceeds the healthy maximum of 70. It has increased from 65.44 (Mar 23) to 81.26, marking an increase of 15.82.
- For Price / BV (X), as of Mar 24, the value is 3.85. This value exceeds the healthy maximum of 3. It has increased from 2.08 (Mar 23) to 3.85, marking an increase of 1.77.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.80. This value is within the healthy range. It has increased from 1.28 (Mar 23) to 2.80, marking an increase of 1.52.
- For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.04, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zensar Technologies Ltd:
- Net Profit Margin: 13.56%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.63% (Industry Average ROCE: 21.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.66% (Industry Average ROE: 64.55%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.82
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.04
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.1 (Industry average Stock P/E: 79.98)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.56%
About the Company - Qualitative Analysis
Zensar Technologies Ltd. is a Public Limited Listed company incorporated on 29/03/1963 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L72200PN1963PLC012621 and registration number is 012621. Currently Company is involved in the business activities of Providing software support and maintenance to the clients. Company's Total Operating Revenue is Rs. 2019.20 Cr. and Equity Capital is Rs. 45.30 Cr. for the Year ended 31/03/2024.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Zensar Knowledge Park, Kharadi, Plot # 4, MIDC, Pune Maharashtra 411014 | investor@zensar.com http://www.zensar.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. H V Goenka | Chairman & Non-Exe.Director |
| Mr. Anant Goenka | Vice Chairman & Non Exe.Dire |
| Mr. Manish Tandon | Managing Director & CEO |
| Mr. Ketan Dalal | Ind. Non-Executive Director |
| Mr. A T Vaswani | Ind. Non-Executive Director |
| Mr. Ben Druskin | Ind. Non-Executive Director |
| Ms. Radha Rajappa | Ind. Non-Executive Director |
| Mr. U B Pravin Rao | Ind. Non-Executive Director |
| Mr. Harsh Mariwala | Ind. Non-Executive Director |
FAQ
What is the latest intrinsic value of Zensar Technologies Ltd?
The latest intrinsic value of Zensar Technologies Ltd as on 12 March 2025 is ₹688.92, which is 7.28% lower than the current market price of 743.00, indicating the stock is overvalued by 7.28%. The intrinsic value of Zensar Technologies Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹16,869 Cr. and recorded a high/low of ₹985/513 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹3,660 Cr and total liabilities of ₹4,822 Cr.
What is the Market Cap of Zensar Technologies Ltd?
The Market Cap of Zensar Technologies Ltd is 16,869 Cr..
What is the current Stock Price of Zensar Technologies Ltd as on 12 March 2025?
The current stock price of Zensar Technologies Ltd as on 12 March 2025 is ₹743.
What is the High / Low of Zensar Technologies Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Zensar Technologies Ltd stocks is ₹985/513.
What is the Stock P/E of Zensar Technologies Ltd?
The Stock P/E of Zensar Technologies Ltd is 26.1.
What is the Book Value of Zensar Technologies Ltd?
The Book Value of Zensar Technologies Ltd is 163.
What is the Dividend Yield of Zensar Technologies Ltd?
The Dividend Yield of Zensar Technologies Ltd is 1.21 %.
What is the ROCE of Zensar Technologies Ltd?
The ROCE of Zensar Technologies Ltd is 25.2 %.
What is the ROE of Zensar Technologies Ltd?
The ROE of Zensar Technologies Ltd is 20.0 %.
What is the Face Value of Zensar Technologies Ltd?
The Face Value of Zensar Technologies Ltd is 2.00.